Person profile
Public information reviewedRoy Freeman, M.D.
Board role
Director · Inhibikase Therapeutics, Inc. (NASDAQ: IKT)
Inhibikase Therapeutics, Inc. (NASDAQ: IKT)
Director · Current mandate
Director
- Public sources
- 2 reviewed
- Profile ownership
- Not yet claimed
- Last reviewed
- May 16, 2026

